Our objectives for this study are to determine the effects of cisplatin on prostate cancer cell growth, the AR and PSA expression, as well as the regulatory mechanisms of cisplatin on the gene expression of BTG2 in prostate cancer cells. The gene discussed is KLK3; the disease is prostate carcinoma.